ASX - Delayed Quote AUD

ResMed Inc. (RMD.AX)

28.32 +0.13 (+0.46%)
As of April 23 at 4:10 PM GMT+10. Market Open.
Loading Chart for RMD.AX
DELL
  • Previous Close 28.19
  • Open 27.83
  • Bid 31.16 x 51100
  • Ask 26.20 x 25600
  • Day's Range 27.80 - 28.42
  • 52 Week Range 21.14 - 36.37
  • Volume 4,206,105
  • Avg. Volume 2,112,785
  • Market Cap (intraday) 41.656B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 30.13
  • EPS (TTM) 0.94
  • Earnings Date --
  • Forward Dividend & Yield 0.29 (1.02%)
  • Ex-Dividend Date Feb 7, 2024
  • 1y Target Est 33.63

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

www.resmed.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMD.AX

Performance Overview: RMD.AX

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RMD.AX
11.50%
S&P 500
6.30%

1-Year Return

RMD.AX
15.05%
S&P 500
22.67%

3-Year Return

RMD.AX
6.25%
S&P 500
22.63%

5-Year Return

RMD.AX
107.08%
S&P 500
74.37%

Compare To: RMD.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMD.AX

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    41.29B

  • Enterprise Value

    43.12B

  • Trailing P/E

    30.13

  • Forward P/E

    22.83

  • PEG Ratio (5yr expected)

    1.72

  • Price/Sales (ttm)

    5.96

  • Price/Book (mrq)

    5.97

  • Enterprise Value/Revenue

    9.57

  • Enterprise Value/EBITDA

    30.16

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.77%

  • Return on Assets (ttm)

    11.19%

  • Return on Equity (ttm)

    21.66%

  • Revenue (ttm)

    4.5B

  • Net Income Avi to Common (ttm)

    890.39M

  • Diluted EPS (ttm)

    0.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    217.86M

  • Total Debt/Equity (mrq)

    31.04%

  • Levered Free Cash Flow (ttm)

    812.89M

Research Analysis: RMD.AX

Analyst Price Targets

30.97
33.63 Average
28.32 Current
45.18 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: RMD.AX

People Also Watch